March Private Market UpdateFebruary shows slight uptick in Forge’s investor interest prior to bank turbulence
March Private Market Update
Pathway Genomics is a biotechnology company focused on providing users with the most validated and personalized healthcare information delivered to any device, the company’s program with IBM Watson is the first of its kind to merge artificial intelligence and deep learning with precision medicine, applicable to both consumers and providers.
| Date | Funding Round | Funding Raised | Price per Share | IPO Valuation |
|---|---|---|---|---|
| 1/5/2016 | Series E-1 | $932.69MM | $XXX.XX | $XXX.XX |
| 11/12/2014 | Series D | $470MM | $XXX.XX | $XXX.XX |
| 4/1/2014 | Series C | $185MM | $XXX.XX | $XXX.XX |
| 7/15/2009 | Series B | $72.48MM | $XXX.XX | $XXX.XX |
| 7/1/2009 | Series A | $14MM | $XXX.XX | $XXX.XX |
